NCT06444009 2024-12-02A Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell CarcinomaWest China HospitalPhase 2 Recruiting90 enrolled